Zymeworks Inc.
@ZymeworksInc
Followers
1K
Following
226
Media
843
Statuses
1K
Zymeworks’ mission is to make a meaningful difference in the lives of people impacted by difficult-to-treat cancers and other diseases.
Vancouver, British Columbia
Joined October 2015
For decades, the paradigm in healthcare was to find drugs that could treat a wide range of patients. But now, it’s becoming increasingly possible to tailor treatments with more precision in a way that’s tailored to a specific patient. Zymeworks Senior Vice President, Clinical
0
0
1
Tomorrow, Dr. Nina E. Weisser, Senior Director of our Multispecific Antibody Therapeutics group, will present at the T-Cell Engager Therapeutics Summit Europe. She’ll be joined by Kara Olson from Regeneron as they share perspectives on advancing next-generation multispecific
0
0
3
Zymeworks is proud to be @JazzPharma's partner on these innovative treatment options for patients. See you at ASCO #GI26
#News for U.S. media and investors: At the ASCO #GI26 Symposium, we'll be presenting Phase 3 data in first-line HER2+ locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). Learn more here: https://t.co/1542xNLmzE
0
0
1
Zymeworks is proud to be a committed and active partner in Singapore’s vibrant biotechnology and pharmaceutical ecosystem. We are fortunate to collaborate with key groups like the Biomedical Sciences Industry Partnership Office (BMSIPO). Please join us in extending
0
0
3
Zymeworks is thrilled to share our continued progress at upcoming conferences in January. Read the full press release: https://t.co/zVM7Gy3Ccp
0
1
1
As Gastric Cancer Awareness Month comes to a close, Zymeworks teams across the globe are wearing periwinkle to honor patients, their loved ones, researchers, and all healthcare professionals advancing care and hope every day. Stomach cancer is the third leading cause of cancer
0
0
2
Zymeworks wishes everyone who celebrates a very happy Thanksgiving. We give thanks to our teams, our partners and everybody working to improve the health and wellbeing of patients around the world.
0
1
4
We’re proud to celebrate Dr. Raffaele Colombo, recipient of the 2024 George R. Pettit Individual Input to the Field Award at this year’s @World_ADC Conference in San Diego. This award recognizes the individual who made the most significant contribution to the #ADC field over the
0
1
2
Looking back on our time at #SITC2025, as the society celebrated 40 years of advancing immunotherapeutic innovation in cancer research! This year, we were proud to present three posters highlighting preclinical progress in #tcellengagers and #antibodydrugconjugates - learn more
0
0
1
Zymeworks is thrilled to meet investors one-on-one and share our continued progress at upcoming investor conferences in December. Read the full press release: https://t.co/rT7KGYgInp
0
0
3
This week marked an exciting new chapter for Zymeworks Inc. as we announced our transition into a new era for the company, following the positive Phase 3 results for zanidatamab in HER2-positive gastric and gastroesophageal cancer and our strategic shift toward a
0
0
2
𝐉𝐞𝐟𝐟𝐞𝐫𝐢𝐞𝐬 𝐋𝐨𝐧𝐝𝐨𝐧: @ZymeworksInc had double-news during London Life Science Week - a P3 success for its HER2 bispecific in gastroesophageal cancer and it also launched a new royalty model. $ZYME Full video: https://t.co/QolhRTkv7G
0
5
10
Zymeworks is thrilled to announced that Scott Platshon will be joining the company as Acting Chief Investment Officer. "Following the positive topline data from the Phase 3 HERIZON-GEA-01 trial, we are strategically positioned to drive long-term returns by building a diversified
0
1
4
Today we're excited to announce a significant evolution in our long-term strategy, one that positions Zymeworks for a more durable, predictable, and value-generating future. Building on the positive Phase 3 data for Ziihera® and the continued advancement of pasritamig, we are
0
1
1
We're excited to announce positive results from the HERIZON-GEA-01 Phase 3 trial, in collaboration with @JazzPharma and @BeOneMedicines. This pivotal study investigated our HER2-targeted bispecific antibody in first-line HER2-positive locally advanced or metastatic
0
2
6
Zymeworks will be attending the Jefferies Global Healthcare Conference in London from November 17–19 for one-on-one meetings. If you’ll be there, we’d love to connect — please reach out to schedule a meeting.
0
0
1
November is Gastric Cancer Awareness Month. Today, we’re taking a closer look at what gastric (stomach) cancer is. According to the AACR, the stomach wall has five layers of tissue: the mucosa, submucosa, muscle layer, subserosa, and serosa. Gastric cancer typically begins in the
0
0
1
Today, we honor and remember those who have served on Remembrance Day in Canada and Veterans Day in the U.S. Thank you to all veterans and active service members for your dedication and sacrifice.
0
0
1